Long-term prednisolone treatments increase bioactive vitamin B 6 synthesis in vivo

Journal of Pharmacology and Experimental Therapeutics

Volumn 337, Issue 1, 2011, Pages 102-109

  Chang, Hsin Yueh ^a   Tzen, Jason T C ^a   Lin, Su Jen ^a   Wu, Yi Ting ^a   Chiang, En Pei Isabel ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; PHOSPHATASE; PREDNISOLONE; PYRIDOXAL; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL 5 PHOSPHATE PHOSPHATASE; PYRIDOXAL KINASE; PYRIDOXAMINE PHOSPHATE OXIDASE; PYRIDOXIC ACID; PYRIDOXINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME ANALYSIS; ERYTHROCYTE; FEMALE; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; RAT; UPREGULATION; URINARY EXCRETION;

ANIMALS; FEMALE; INFLAMMATION MEDIATORS; MICE; MICE, INBRED C57BL; PREDNISOLONE; RATS; RATS, INBRED LEW; TIME FACTORS; TISSUE DISTRIBUTION; VITAMIN B 6;

EID: 79952995835     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.174839     Document Type: Article

References (40)

1. Bosron WF, Veitch RL, Lumeng L, and Li TK (1978) Subcellular localization and identification of pyridoxal 5′-phosphate-binding proteins in rat liver. J Biol Chem 253:1488-1492. (Pubitemid 8303450)
2. Buttgereit F, da Silva JA, Boers M, Burmester GR, Cutolo M, Jacobs J, Kirwan J, Köhler L, Van Riel P, Vischer T, et al. (2002) Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis 61:718-722. (Pubitemid 34787710)
3. Chatterjee AK (1980) Possible influence of gonadotrophins on formation in vivo of pyridoxal phosphate. Horm Metab Res 12:397-399.
4. Chiang EP, Bagley PJ, Roubenoff R, Nadeau M, and Selhub J (2003a) Plasma pyridoxal 5′-phosphate concentration is correlated with functional vitamin B-6 indices in patients with rheumatoid arthritis and marginal vitamin B-6 status. J Nutr 133:1056-1059. (Pubitemid 36407124)
5. Chiang EP, Bagley PJ, Selhub J, Nadeau M, and Roubenoff R (2003b) Abnormal vitamin B(6) status is associated with severity of symptoms in patients with rheumatoid arthritis. Am J Med 114:283-287. (Pubitemid 36398073)
6. Chiang EP, Selhub J, Bagley PJ, Dallal G, and Roubenoff R (2005a) Pyridoxine supplementation corrects vitamin B6 deficiency but does not improve inflammation in patients with rheumatoid arthritis. Arthritis Res Ther 7:R1404-R1411.
7. Chiang EP, Smith DE, Selhub J, Dallal G, Wang YC, and Roubenoff R (2005b) Inflammation causes tissue-specific depletion of vitamin B6. Arthritis Res Ther 7:R1254-R1262.
8. Chiang EP, Wang YC, Chen WW, and Tang FY (2009) Effects of insulin and glucose on cellular metabolic fluxes in homocysteine transsulfuration, remethylation, S-adenosylmethionine synthesis, and global deoxyribonucleic acid methylation. J Clin Endocrinol Metab 94:1017-1025.
9. Chiang EP, Wang YC, and Tang FY (2007) Folate restriction and methylenetetra-hydrofolate reductase 677T polymorphism decreases adoMet synthesis via folate-dependent remethylation in human-transformed lymphoblasts. Leukemia 21:651-658.
10. Chen DY, Chih HM, Lan JL, Chang HY, Chen WW, and Chiang EP (2011) Blood lipid profiles and peripheral blood mononuclear cell cholesterol metabolism gene expressions in patients with and without methotrexate treatment. BMC Med 9:4.
11. Eisenstein AB (1960) Relationship of vitamin B6 to gluconeogenic action of cortisol. Endocrinology 67:97-101.
12. Ellis JM and McCully KS (1995) Prevention of myocardial infarction by vitamin B6. Res Commun Mol Pathol Pharmacol 89:208-220.
13. Fonda ML and Harker CW (1982) Metabolism of pyridoxine and protein binding of the metabolites in human erythrocytes. Am J Clin Nutr 35:1391-1399. (Pubitemid 12024967)
14. Francisco GE, Honigberg IL, Stewart JT, Kotzan JA, Brown WJ, Schary WL, Pelsor FR, and Shah VP (1984) In vitro and in vivo bioequivalence of commercial prednisone tablets. Biopharm Drug Dispos 5:335-344. (Pubitemid 15188895)
15. Friso S, Girelli D, Martinelli N, Olivieri O, Lotto V, Bozzini C, Pizzolo F, Faccini G, Beltrame F, and Corrocher R (2004) Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. Am J Clin Nutr 79:992-998. (Pubitemid 41095950)
16. Gavosto F, Pileri A, and Brusca A (1957) Increased transaminase activity in the liver after administration of cortisone. Biochim Biophys Acta 24:250-254.
17. Gotzsche PC and Johansen HK (2004) Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Cochrane Database Syst Rev CD000189. Review.
18. Gregory JF 3rd and Kirk JR (1979) Determination of urinary 4-pyridoxic acid using high performance liquid chromatography. Am J Clin Nutr 32:879-883.
19. Ink SL, Mehansho H, and Henderson LM (1982) The binding of pyridoxal to hemoglobin. J Biol Chem 257:4753-4757. (Pubitemid 12063173)
20. Joosten LA, Helsen MM, Saxne T, Heinegård D, van de Putte LB, and van den Berg WB (1999) Synergistic protection against cartilage destruction by low dose prednisolone and interleukin-10 in established murine collagen arthritis. Inflamm Res 48:48-55.
21. Kim MH, Kim E, Passen EL, Meyer J, and Kang SS (1997) Cortisol and estradiol: nongenetic factors for hyperhomocyst(e)inemia. Metabolism 46:247-249. (Pubitemid 27106779)
22. Krebs EG and Fischer EH (1964) Phosphorelase and related enzymes of glycogen metabolism. Vitam Horm 22:399-410.
23. Lazzerini PE, Capecchi PL, Bisogno S, Galeazzi M, Marcolongo R, and Pasini FL (2003) Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. Ann Rheum Dis 62:694-695. (Pubitemid 36760583)
24. Lumeng L, Brashear RE, and Li TK (1974) Pyridoxal 5′-phosphate in plasma: source, protein-binding, and cellular transport. J Lab Clin Med 84:334-343.
25. Lumeng L, Lui A, and Li TK (1980) Plasma content of B6 vitamers and its relationship to hepatic vitamin B6 metabolism. J Clin Invest 66:688-695. (Pubitemid 10060937)
26. Mahuren JD, Dubeski PL, Cook NJ, Schaefer AL, and Coburn SP (1999) Adrenocorticotropic hormone increases hydrolysis of B-6 vitamers in swine adrenal glands. J Nutr 129:1905-1908. (Pubitemid 29468607)
27. Mehansho H and Henderson LM (1980) Transport and accumulation of pyridoxine and pyridoxal by erythrocytes. J Biol Chem 255:11901-11907. (Pubitemid 11132206)
28. Pham V, Zhang W, Chen V, Whitney T, Yao J, Froese D, Friesen AD, Diakur JM, and Haque W (2003) Design and synthesis of novel pyridoxine 5′-phosphonates as potential antiischemic agents. J Med Chem 46:3680-3687. (Pubitemid 36988655)
29. Pickup ME (1979) Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokinet 4:111-128.
30. Robinson K, Arheart K, Refsum H, Brattström L, Boers G, Ueland P, Rubba P, Palma-Reis R, Meleady R, Daly L, et al. (1998) Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation 97:437-443. (Pubitemid 28090214)
31. Rosen F, Roberts NR, Budnick LE, and Nichol CA (1959a) Corticosteroids and transaminase activity: the specificity of the glutamic-pyruvic transaminase response. Endocrinology 65:256-264.
32. Rosen F, Roberts NR, and Nichol CA (1959b) Glucocorticosteroids and transaminase activity. I. Increased activity of glutamicpyruvic transaminase in four conditions associated with gluconeogenesis. J Biol Chem 234:476-480.
33. Schäcke H, Döcke WD, and Asadullah K (2002) Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96:23-43.
34. Schwahn BC, Wendel U, Lussier-Cacan S, Mar MH, Zeisel SH, Leclerc D, Castro C, Garrow TA, and Rozen R (2004) Effects of betaine in a murine model of mild cystathionine-β-synthase deficiency. Metabolism 53:594-599. (Pubitemid 38596531)
35. Serfontein WJ, Ubbink JB, De Villiers LS, Rapley CH, and Becker PJ (1985) Plasma pyridoxal-5-phosphate level as risk index for coronary artery disease. Atherosclerosis 55:357-361. (Pubitemid 15000537)
36. Smolin LA, Crenshaw TD, Kurtycz D, and Benevenga NJ (1983) Homocyst(e)ine accumulation in pigs fed diets deficient in vitamin B-6: relationship to atherosclerosis. J Nutr 113:2022-2033. (Pubitemid 14236249)
37. Talwar D, Quasim T, McMillan DC, Kinsella J, Williamson C, and O'Reilly DS (2003) Optimisation and validation of a sensitive high-performance liquid chromatography assay for routine measurement of pyridoxal 5-phosphate in human plasma and red cells using pre-column semicarbazide derivatisation. J Chromatogr B Analyt Technol Biomed Life Sci 792:333-343.
38. Ubbink JB and Schnell AM (1988) High-performance liquid chromatographic assay of erythrocyte enzyme activity levels involved in vitamin B6 metabolism. J Chromatogr 431:406-412.
39. Wada H and Snell EE (1961) The enzymatic oxidation of pyridoxine and pyridoxamine phosphates. J Biol Chem 236:2089-2095.
40. Wang YC, Chen YM, Lin YJ, Liu SP, Chiang EP (2011) GNMT expression increases hepatic folate contents and folate-dependent methionine synthase-mediated homocysteine remethylation. Mol Med doi:10.2119/molmed.2010. 00243.